#India #COVID19 #Covaxin #CovidVaccine #CovidVaccineHumanTrial

Bhubaneswar (Odisha), Nov 21 (ANI): Phase-3 trial of Covaxin is very crucial, and this is the largest clinically phase-3 trial in India, said Dr. E Venkata Rao, Principal Investigator in the Covaxin human trial to ANI on November 21. He said, “After the success of Phase-1 and 2 of this indigenously developed vaccine by Bharat Biotech. Now the vaccine has come in to the phase-3, phase-1 was the safety profile, and in phase-2 we looked for antibodies which are sufficiently developed in the body or not.

--------------------------------------
Subscribe now! Enjoy and stay connected with us!!
☛ Subscribe ANI News channel: [ Ссылка ]
☛ Visit our Official website: [ Ссылка ]
☛ Follow ANI News: [ Ссылка ]
☛ Like us: [ Ссылка ]
☛ Email to Shrawan K Poddar: shrawankp@aniin.com
☛ Copyrights © All Rights Reserved ANI Media Pvt Ltd.

свернуть